The Latest Developments in Pain Management Devices

Pain Management Devices latest technology

1. Wearable Pain Management Devices: Wearable pain management devices use various technologies to provide relief from chronic pain. Examples include TENS (Transcutaneous Electrical Nerve Stimulation) units, ultrasound devices, electrical stimulation devices, and laser therapy units. These devices can be used at home or in the clinic to provide a non-invasive, drug-free approach to pain relief.

2. Neuromodulation Devices: Neuromodulation devices are used to treat chronic pain by stimulating the nervous system. Examples include spinal cord stimulators, intrathecal pumps, and peripheral nerve stimulators. These devices can help reduce pain signals being sent to the brain.

3. Virtual Reality Therapy: Virtual reality therapy is used to help manage chronic pain by providing distraction and relaxation techniques. Patients can experience virtual environments and interact with avatars to help reduce their pain levels.

4. Biofeedback Devices: Biofeedback devices measure a person’s physiological responses to help them better understand their body’s responses to pain. This information can then be used to help them manage their pain more effectively.

Medtronic spinal cord stimulation technology

Medtronic offers a wide range of spinal cord stimulation (SCS) technologies and therapies designed to help reduce chronic pain. These technologies use small electrical pulses to modulate the pain signals sent to the brain. Medtronic SCS therapies can be used to target specific areas of the body to help reduce back and leg pain, as well as other chronic pain conditions. Medtronic SCS systems are designed to be easily implanted, and offer patients an adjustable, customizable solution to address their individual pain needs. The newest Medtronic SCS system, the RestoreUltra Stimulator, is designed to provide the most advanced SCS therapy available today. This system offers advanced features and therapies, including burst stimulation, which can help to reduce chronic pain more effectively than traditional stimulation.

In January 2020, Medtronic launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity

Bostonscientific Pain Management Products

Boston Scientific offers a comprehensive range of pain management products to help alleviate pain and improve patient outcomes. The company’s portfolio includes radiofrequency ablation systems, neuromodulation systems, injection systems, and percutaneous nerve evaluation systems. Boston Scientific also offers a range of accessories, such as sterile single-use electrodes, electrodes with integrated leads, and electrode kits. The company’s products are designed to meet the unique needs of each patient, providing a personalized approach to pain management.

In June 2019, Boston Scientific acquired Vertiflex, Inc. (US), a the privately held developer of the Superion Indirect Decompression System, a minimally invasive device used to improve physical functions and reduce pain in patients with lumbar spinal stenosis (LSS).

Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players. The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6%. MarketsandMarkets gathers and analyses raw data across 10 major B2B verticals to provide market intelligence that enables companies to outperform competitors improve current offerings and detect market disruptions early. We also identify new-age business opportunities, develop market entry strategies and actionable insights so our clients can enjoy first-mover advantage.

Related Links